KIF1A

JULY 22, 2023

2023 Scientific findings need to be validated, replicated, and applied to new systems; this is the reason KIF1A.ORG has invested in our Treatment Accelerator Program. Read the Article The post #ScienceSaturday: July 22, 2023 appeared first on KIF1A. ” Chai et al.

Small Molecule 98

Small Molecule FDA Disease Treatment 98

Drug Patent Watch

DECEMBER 10, 2024

They can help ensure that these submissions are complete, accurate, and timely, which is critical for advancing drug development programs. 2023, November 17). CDMOs and How They Support Business Development. 2023, October 12). 2023, June 23). References: Ellis, J. link] Societal CDMO. Societal CDMO.

Compliance 96

Compliance Pharmaceuticals Pharmaceutical Companies Regulations 96

Conversations in Drug Development Trends

AUGUST 10, 2023

With so many exciting developments in the last few years, it’s critical for the psychedelic community to come together to reflect on our progress, share the latest discoveries, and discuss the future of psychedelic research. The post 3 Key Takeaways from Psychedelic Science 2023 appeared first on Worldwide Clinical Trials.

Science 98

Science Clinical Trials Trials Clinical Research 98

SCIENMAG: Medicine & Health

JUNE 27, 2023

HOUSTON – (June 27, 2023) – Many of the drugs we use to treat cancer and infectious disease are ⎯ or derive from ⎯ natural products, but it’s difficult to know exactly how nature assembles them. Credit: (Photo by Gustavo Raskosky/Rice University) HOUSTON – (June 27, 2023) – Many of the drugs we use to […]

Drug Development 77

Drug Development Drugs Disease Production 77

FDA Law Blog: Biosimilars

JUNE 27, 2023

Valentine Named Top Lawyer Under 40; Only Food and Drug Lawyer Selected Hyman, Phelps & McNamara, P.C. (HP&M) Valentine , as a 2023 Rising Star. James was only one of five life sciences attorneys selected and the only food and drug lawyer to make the list. HP&M’s Kurt R. Gibbs Paul M. Hyman Alan M. Mullen Frank J.

Science 81

Science FDA Approval FDA Drug Development 81

Perficient: Drug Development

JUNE 26, 2023

We’re thrilled to announce that Perficient has been recognized as a 2023 Top Workplace by the St. Congratulations to the other 2023 Top Workplaces in St. Louis Post Dispatch. This award is a proven testament that underscores our ongoing commitment to fostering an exceptional work environment for our colleagues.

Research 97

Research 97

Covalent Modifiers

OCTOBER 24, 2023

Jones ACS Medicinal Chemistry Letters 2023 DOI: 10.1021/acsmedchemlett.3c00371 3c00371 Site-specific modification of amino acid residues in protein binding pockets using sulfonyl exchange chemistry expands the druggable proteome by enabling the development of covalent modulators that target residues beyond cysteine. Nowak, Katherine A.

Metabolic Stability 173

Metabolic Stability Drug Development Drugs 173

Drug Target Review

APRIL 7, 2025

In a recent survey conducted by ICON, Plc, biomarker selection was identified by 35 percent of respondents as a top challenge among drug developers for phase I trials, second only to navigating regulatory compliance (- 38 percent). Silver Spring (MD): Food and Drug Administration (US); 2016-. Rodrigues AD. 113:9861002.

Clinical Development 69

Clinical Development Clinical Trials Clinical Pharmacology Trials 69

Perficient: Drug Development

AUGUST 4, 2023

The Digital Transformation Services Landscape, Q3 2023 Report The recently published Forrester report defines digital transformation services as “Service providers that enable companies to leverage modern technology, practices, and ecosystems to deliver new sources of value and continuously improve business outcomes.”

Marketing 98

Marketing Research Production 98

PPD

JANUARY 2, 2025

Its ability to maneuver persistent drug development challenges, like patient recruitment, trial complexity and rising costs, will ultimately determine its success.

Clinical Development 98

Clinical Development Clinical Trials Trials Regulations 98

Perficient: Drug Development

APRIL 22, 2024

Perficient achieved the Köerber 2023 Evolve Partner Award for New OMS Partner of the Year North America. We’re excited to share some wonderful news with you all! We see this as a shared achievement, one that wouldn’t be possible without the support of our incredible team and partner Köerber.

Marketing 98

Marketing 98

Fierce BioTech

DECEMBER 1, 2023

The Essential Roadmap to Drug Development for Bioanalytical Success Discover the 3 pillars of successful PK testing and conquer bioanalytical challenges with this whitepaper’s insights. png Fri, 12/01/2023 - 08:00 Biotech Biotech Landing Page Url [link] Byline Sponsored by: Sannova Analytical Download now.

Drug Development 52

Drug Development Drugs 52

The Premier Consulting Blog

APRIL 13, 2025

On April 10, 2025, the US FDA announced that it has a long-term plan to eliminate conventional animal testing in drug development, starting with monoclonal antibodies (mAbs).[ from approved products in other countries) to inform doses and development. Legislation with delayed implementation In 2021, the FDA Modernization Act 2.0

Animal Testing 52

Animal Testing FDA Drug Development Production 52

Drug Patent Watch

DECEMBER 10, 2024

Generic drug development is a complex process that requires a deep understanding of regulatory requirements and guidelines. Regulatory expertise plays a crucial role in ensuring that generic drugs meet the necessary standards for quality, safety, and efficacy. ” Scientific Research Publishing , 2024. ” U.S.

Drug Development 52

Drug Development Compliance Drugs Regulations 52

Perficient: Drug Development

OCTOBER 23, 2023

Join us at SF Jazz in San Francisco or tune in virtually to connect with Perficient, learn from our experts, and discover the future of web development. Conference 2023! See you at the Next.js

103

103

Perficient: Drug Development

JULY 3, 2023

” – Doug Crandall , Account Developer Check out what our team in Southern California has been up to lately: Click to view slideshow. Congratulations to the other 2023 Best Places to Work in Orange County on your commitment to cultivating a workplace where your employees feel heard, recognized, and most importantly, valued.

Research 96

Research 96

FDA Law Blog: Drug Discovery

APRIL 21, 2025

One area drawing increasing attention is how these changes will affect the drug development and review process. As reported by the Wall Street Journal last week , reviews of both innovative and follow-on drugs have been caught in a traffic jam, largely due to a leadership vacuum at the Center for Drug Evaluation and Research (CDER).

FDA 64

FDA Drug Development Drugs International 64

Alta Sciences

AUGUST 29, 2024

Engaging at the outset with a fully integrated and experienced drug development partner can ensure safety, with timely data sharing at every step of the drug development plan, and facilitate agile, flexible decision-making and planning. billion USD in 2023 to $166.53 billion USD by 2028. Image thumbnail-qh33.jpg

Drug Development 52

Drug Development Small Molecule Clinical Trials Drugs 52

Conversations in Drug Development Trends

DECEMBER 7, 2023

Other drawbacks reported from working with these large CROs were: These performance disruptions and drawbacks have resulted in an environment of uncertainty among this CRO service provider segment in 2023, with likely ramifications extending into 2024 and beyond.

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

Drug Patent Watch

DECEMBER 12, 2024

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to outsource various stages of drug development and manufacturing. With the increasing complexity of drug development and the need for efficient, cost-effective solutions, selecting the right CDMO is crucial.

Drug Development 94

Drug Development Production Pharmaceutical Companies Clinical Trials 94

Drug Target Review

JULY 7, 2025

Non-human primates (NHPs), such as macaques and cynomolgus monkeys, have long served as a cornerstone in preclinical drug development due to their close genetic, anatomical and physiological resemblance to humans. Federal ruling on USDA primate welfare petition, 2023. Food and Drug Administration (FDA). USDA (2020).

Drug Research 52

Drug Research Research Animal Testing Drugs 52

Perficient: Drug Development

OCTOBER 2, 2023

Optimizely’s Opticon 2023 begins next week on Tuesday, October 10 in sunny San Diego. Opticon 2023 Agenda Highlights Opticon Opening Keynote with Zoom Optimizely CEO Alex Atzberger and Chief Product Officer Rupali Jain will guide attendees through the Optimizely roadmap and showcase the latest product developments.

Science 59

Science Production 59

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues. Asia, and Europe.

Drug Development 52

Drug Development Treatment Drugs FDA Approval 52

Metabolite Tales Blog

APRIL 10, 2024

Where data was publicly available, the routes of human metabolism for each of the drugs in this subset is listed in Table 1. It is proposed that the decreased clearance of the drug observed in patients may be due to depletion of GSH in this population [10]. Drug Metab Dispos. 2023; 51(7):873-883. 2023; 62(12):1765-1779.

Small Molecule 59

Small Molecule FDA Approval FDA Pharmacokinetics 59

SugarCone Biotech

JUNE 19, 2025

Tarlatamab triggered an ORR of ~40% in refractory (second-line or later) SCLC patients in the DeLLphi-301 clinical trial published in 2023. The Next Wave: Targeting B7H3 – a drug development tsunami in the making? CD3 binding activates the T cells to attack and kill any cell that expresses DLL3, thus killing SCLC cells.

Therapies 78

Therapies Clinical Trials Treatment Clinical Development 78

Perficient: Drug Development

SEPTEMBER 7, 2023

This year´s the me for Offsite 2023 was grilling, one of the most popular activities for “regios” or people born and raised in Monterrey. Our colleagues prepared steak kebabs with melted cheese, hamburgers, and other barbecue favorites at Offsite 2023.

59

59

Alta Sciences

JUNE 6, 2025

For a contract research organization (CRO), it can play an integral role in increasing the quality and speed of drug development while reducing costs, repetitive manual tasks, and human error. This can result in failed runs and wasted reagents.

Pharmacokinetics 52

Pharmacokinetics Molecular Biology Drug Development Pharmaceutical Companies 52

Perficient: Drug Development

FEBRUARY 29, 2024

Perficient is excited to announce we’ve won the 2023 Acquia Partner Advocate of the Year Award for North America ! Perficient has obtained 7+ Acquia Engage awards including our recent 2023 win. This award commemorates a partner that has exhibited outstanding performance and industry leadership.

Regulations 64

Regulations Production Marketing 64

Drug Target Review

SEPTEMBER 22, 2023

They have the capacity to differentiate tissue-specific cell types that mimic the architecture and complexity of human organs, from brain, 3 to gut, 4 providing a platform for preclinical testing of new drugs, high-throughput drug screening and long-term toxicity screening. 2023 May;30(5):571–91. billion by 2030.

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

Conversations in Drug Development Trends

NOVEMBER 10, 2023

The post 3 Considerations of the Patient Perspective from the 2023 Pain Therapeutics Summit appeared first on Worldwide Clinical Trials. I am humbled to work with my peers who are as passionate, empathetic, and understanding of these patients in need.

Clinical Trials 75

Clinical Trials Trials Treatment Doctors 75

Perficient: Drug Development

SEPTEMBER 22, 2023

Two statistics she shared stood out to me: First, on average, healthcare organizations have 46 systems in place dedicated to operations (Source: Salesforce Research, Healthcare & Life Sciences, April 2023). At Perficient, we have seen this firsthand, many times.

Science 59

Science Clinical Trials Engineering Production 59

SCIENMAG: Medicine & Health

AUGUST 23, 2023

KANSAS CITY, MO—August 23, 2023—With around 90% of drugs failing to make it to market, the potential for improving efficiency within the drug development industry is clear. Drugs designed to combat cancers suffer similar rates of failure for many reasons.

Drugs 87

Drugs Drug Development Marketing Research 87

Perficient: Drug Development

NOVEMBER 29, 2023

As you can gather from the above, MWC 2023 provided valuable insights into the latest trends and innovations in the CMT industry. If you’re interested in diving deeper into the above takeaways from MWC 2023 or would like to understand how our CMT industry expertise can benefit your business, contact us today.

Marketing 52

Marketing 52

Perficient: Drug Development

JUNE 6, 2023

List of Top 7 Content Management Systems for Your Digital Success in 2023 Here is an overview of the best CMS solutions in 2023 based on their tech features, user experience, functionality, etc. Is there a community of users that can offer help and support when you need it?

Marketing 59

Marketing Production Government 59

Perficient: Drug Development

DECEMBER 22, 2023

He covered many topics in 2023, all of which can still guide companies as we head into 2024: Emotions in Marketing: The Art of Anticipatory Customer Experience – Creating lifelong customers hinges on eliciting emotions, anticipation, and nostalgia, rather than relying on promotions or pricing strategies.

Production 64

Production Marketing Research 64

Perficient: Drug Development

NOVEMBER 6, 2023

We are excited to share the news that Perficient has been named a 2023 Top Workplaces winner in the Dallas-Fort Worth region, thanks to the company culture that we have cultivated. Several of our colleagues in the Dallas area are enthusiastic fans of the Mavericks so getting to team up with them is a wonderful perk every year.

Engineering 52

Engineering International Marketing 52

SCIENMAG: Medicine & Health

AUGUST 9, 2023

August 9, 2023 — Critical Path Institute (C-Path) announced today that Sanofi, a global leader in immunology and diabetes care, has joined its Type 1 Diabetes Consortium (T1DC). TUCSON, Ariz., Sanofi joins T1DC as part of its commitment to push the boundaries of innovation to improve the lives of those with diabetes.

Drug Development 57

Drug Development Drugs 57